These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8241462)

  • 1. Interleukin-2 enhances scopolamine-induced amnesia and hyperactivity in the mouse.
    Bianchi M; Panerai AE
    Neuroreport; 1993 Aug; 4(8):1046-8. PubMed ID: 8241462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripherally administered IL-1 alpha interferes with scopolamine-induced amnesia in mice.
    Bianchi M; Panerai AE
    Brain Res Cogn Brain Res; 1993 Dec; 1(4):257-9. PubMed ID: 8003924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripherally administered GM-CSF interferes with scopolamine-induced amnesia in mice: involvement of interleukin-1.
    Bianchi M; Sacerdote P; Panerai AE
    Brain Res; 1996 Aug; 729(2):285-8. PubMed ID: 8877002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of molsidomine on scopolamine-induced amnesia and hypermotility in the rat.
    Pitsikas N; Rigamonti AE; Cella SG; Locatelli V; Sala M; Muller EE
    Eur J Pharmacol; 2001 Aug; 426(3):193-200. PubMed ID: 11527544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 affects scopolamine-induced amnesia, but not brain amino acid levels in mice.
    Bianchi M; Ferrario P; Clavenna A; Panerai AE
    Neuroreport; 1997 May; 8(7):1775-8. PubMed ID: 9189931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of central muscarinic blockade on passive avoidance: anterograde amnesia, state dependency, or both?
    Quirarte GL; Cruz-Morales SE; Cepeda A; García-Montañez M; Roldán-Roldán G; Prado-Alcalá RA
    Behav Neural Biol; 1994 Jul; 62(1):15-20. PubMed ID: 7945140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nootropic drugs in a scopolamine-induced amnesia model in mice.
    Verloes R; Scotto AM; Gobert J; Wülfert E
    Psychopharmacology (Berl); 1988; 95(2):226-30. PubMed ID: 3137602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of scopolamine-induced amnesia by the GABAB receptor antagonist CGP 35348 in the mouse.
    Bianchi M; Panerai AE
    Brain Res Cogn Brain Res; 1993 Apr; 1(2):135-6. PubMed ID: 8390321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hachimijiogan, an oriental herbal medicinal mixture, on experimental amnesia in mice.
    Hirokawa S; Nose M; Ishige A; Amagaya S; Ogihara Y
    Biol Pharm Bull; 1994 Sep; 17(9):1182-6. PubMed ID: 7841938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pro-amnesic efficacy of scopolamine, biperiden, and phencyclidine by using passive avoidance task in CD-1 mice.
    Malikowska N; Sałat K; Podkowa A
    J Pharmacol Toxicol Methods; 2017 Jul; 86():76-80. PubMed ID: 28412329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Uncaria tomentosa total alkaloid and its components on experimental amnesia in mice: elucidation using the passive avoidance test.
    Mohamed AF; Matsumoto K; Tabata K; Takayama H; Kitajima M; Watanabe H
    J Pharm Pharmacol; 2000 Dec; 52(12):1553-61. PubMed ID: 11197086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reduction in electric footshocks perception interferes with the amnesic effect of scopolamine.
    Torquet N; Hagues G; Costentin J
    Behav Brain Res; 2008 Mar; 188(1):238-40. PubMed ID: 18160109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of insulin and melatonin on acetylcholinesterase activity in the brain of amnesic mice.
    Agrawal R; Tyagi E; Shukla R; Nath C
    Behav Brain Res; 2008 Jun; 189(2):381-6. PubMed ID: 18336929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term administration of berberine on scopolamine-induced amnesia in rats.
    Peng WH; Hsieh MT; Wu CR
    Jpn J Pharmacol; 1997 Jul; 74(3):261-6. PubMed ID: 9268086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of piracetam's anti-amnesic activity in three models of amnesia in the mouse.
    Lenègre A; Chermat R; Avril I; Stéru L; Porsolt RD
    Pharmacol Biochem Behav; 1988 Mar; 29(3):625-9. PubMed ID: 3362958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of eurystatins A and B, new prolyl endopeptidase inhibitors, on scopolamine-induced amnesia in rats.
    Kamei H; Ueki T; Obi Y; Fukagawa Y; Oki T
    Jpn J Pharmacol; 1992 Dec; 60(4):377-80. PubMed ID: 1287273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of scopolamine-induced amnesia by phosphatidylserine in rats.
    Zanotti A; Valzelli L; Toffano G
    Psychopharmacology (Berl); 1986; 90(2):274-5. PubMed ID: 3097711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cholinergic neurotransmission in the amygdala on performances of passive avoidance learning in mice.
    Nomura Y; Nishiyama N; Saito H; Matsuki N
    Biol Pharm Bull; 1994 Apr; 17(4):490-4. PubMed ID: 8069254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttraining administration of gastrin-releasing peptide improves memory loss in scopolamine- and hypoxia-induced amnesic mice.
    Santo-Yamada Y; Yamada K; Wada K
    Physiol Behav; 2001 Sep 1-15; 74(1-2):139-43. PubMed ID: 11564462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen levels modify scopolamine-induced amnesia in gonadally intact rats.
    de Macêdo Medeiros A; Izídio GS; Sousa DS; Macedo PT; Silva AF; Shiramizu VK; Cabral A; Ribeiro AM; Silva RH
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():99-108. PubMed ID: 24657885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.